| DelveInsight The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based ...
The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based therapies ...
MHRA registration authorizes hp+detect™ for commercial sale in Great BritainActive Commercialization: Biomerica is in active ...
Morning Overview on MSN
This stealthy bacteria could trigger millions of cancer cases worldwide
A single bacterium that silently colonizes the stomachs of billions of people could be responsible for roughly 12 million ...
The findings of a new study suggest a possible association between H. pylori infection and the pathophysiology of vitiligo. Based on this link, H. pylori eradication therapy may serve as ...
H. pylori is widely recognised by clinicians as one of the leading causes of chronic gastric conditions in the country. For weeks, Epiphanie Nyiransabimana watched her son struggle with persistent ...
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...
A doctor yesterday reminded people not to take certain types of drugs before getting a stool antigen test for Helicobacter pylori amid a one-time government-funded testing program for people aged 45 ...
I would no longer need to take the above medications.
RedHill Biopharma announces full sales and operational launch of Talicia in US: Raleigh, North Carolina Friday, February 27, 2026, 13:00 Hrs [IST] RedHill Biopharma Ltd., a specia ...
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, today announced the launch of its national sales promotional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results